Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.
Choose from the criteria below to find an activity that fits you best.
|This activity is available for $149 to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.|
|A product of the National Association of Specialty Pharmacy's (NASP) Center for Specialty Pharmacy Education (CSPE)|
Specialty pharmacy is the fastest growing segment of pharmacy practice today and will continue for the foreseeable future. Specialty pharmacy impacts only a small percent of the population; however, the diseases and drug therapies are very complex and require a higher level of knowledge compared to more traditional diseases and drug therapies. The Certified Specialty Pharmacist Credential is designed to validate your professional expertise, elevate the status of the specialty pharmacy profession, differentiate yourself in a competitive job market, position yourself for handling limited or exclusively distributed drugs, position yourself to better serve payer requirements, and protect the public by improving their health outcomes and reducing medication errors.
The CSP Exam Preparatory Course will cover aspects of Clinical, Fulfillment, Intake and Outcomes that might be expected on the exam. Join expert faculty as key aspects of specialty pharmacy and the specialty pharmacist’s role are discussed. Key topics include the fundamentals and considerations for the patient intake process, as well as fulfillment workflows, quality assurance and dispensing channels. Outcomes measures and standards are covered, and clinical modules review persistence and adherence, specialty drug classes, indications, interactions, and more.
The target audience for this activity includes pharmacists.
|At the completion of Inflammatory
Diseases, participants will be able to:
||At the completion of HIV, participants will
be able to:
Aimee Banks, PharmD, BCPS (Multiple Sclerosis)
Clinical Pharmacist, Multiple Sclerosis Clinic
Vanderbilt University Medical Center
Jeff Engle, PharmD, MS (Oncology)
Oncology/Hematology Clinical Pharmacist
Fairview Specialty Pharmacy
University of Minnesota Masonic Cancer Clinic
April Jones, PharmD, CSP (Inflammatory Diseases)
Clinical Pharmacist, Specialty Pharmacy Services
Vanderbilt University Medical Center
Kanika Kapoor, PharmD, CSP (Intake, Clinical Management, Outcomes &
Clinical Pharmacist, Diplomat Pharmacy
Brandon M. Markley, PharmD, BCPS (Multiple Sclerosis)
Clinical Pharmacist, Vanderbilt University Medical Center
Multiple Sclerosis Clinic
Kevn McNamara, PharmD (Hemophilia, Immunoglobulin (Ig) Therapy. Intake,
Clinical Management, Outcomes & Fulfillment)
Owner-Manager, Clinical Pharmacy Partners
Jackie Senogles, PharmD, CSP (Intake, Clinical Management, Outcomes &
Fairview Pharmacy Services
Melissa (Mel) Nelson, PharmD, CSP (Intake, Clinical Management, Outcomes
Specialty Pharmacy Manager, Fairview Pharmacy Services
Erin Stack Mellerski, PharmD (Hemophilia, Immunoglobulin (Ig) Therapy)
Supervising Pharmacist, Cottrill’s Specialty Pharmacy
Kristen Whelchel, PharmD (HIV, Hepatitis)
Vanderbilt Specialty Pharmacy
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed in this activity. None of the speakers have any relevant commercial or financial relationships to disclose.
Please note: The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.
Release Date: 07-10-2019
Expiration Date: 07-10-2022
This CE activity is jointly provided by ProCE, Inc. and NASP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Numbers 0221-9999-19-276-H01-P, 0221-9999-19-277-H01-P, 0221-9999-19-278-H01-P, 0221-9999-19-279-H01-P, 0221-9999-19-280-H01-P, 0221-9999-19-281-H01-P, 0221-9999-19-282-H01-P, 0221-9999-19-283-H04-P have been assigned to these knowledge-based home-study CE activities (initial release date 07-10-19). These activities (8 individual activities) are approved for a maximum of 5.8 total contact hours (0.58 CEU) in states that recognize ACPE providers. Completion of the evaluations and the post-tests with a score of 70% or higher are required to receive CE credit. No partial credit will be given.
No external support has been received for this activity.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.